DIRS.INFO The most relevant business & tech news

Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsCOPENHAGEN, Nov 2 (Reuters) - Novo Nordisk (NOVOb.CO) on Thursday reported record sales and operating profits for the third quarter but said it would keep in place restrictions on supplies of its hugely popular Wegovy weight-loss drug. Wegovy sales totaled 9.6 billion Danish crowns ($1.36 billion) between July and September, up 28% from the previous quarter and up eight-fold from the same period last year. In August, Novo said the curbs on Wegovy supplies would most likely extend into 2024. Sales grew 29% year-on-year to 58.7 billion Danish crowns ($8.33 billion), while operating profit (EBIT) rose 33% to 26.9 billion, both in line with preliminary numbers released last month.

Persons: Tom Little, Wegovy, Novo, Eli Lilly, Jacob Gronholt, Pedersen, Terje Solsvik Organizations: Novo Nordisk, Danish, REUTERS, Rights, European Union, U.S . Food, Drug Administration, Thomson Locations: Copenhagen, Denmark, U.S, United States

☆ Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
▼ + stars: | 2023-11-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Novo Nordisk on Thursday said 80% of U.S. patients with insurance coverage who take its highly popular weight loss treatment Wegovy are paying less than $25 a month for the drug. He estimated that about 50 million Americans with obesity could be eligible for Wegovy coverage under their health plans. Most patients have to take Wegovy for several months to see — and sustain — significant weight loss. Wegovy, for example, leads to 15% weight loss after 68 weeks, according to clinical trials on the drug. But Novo Nordisk is hoping that new data demonstrating the heart health benefits of Wegovy will put more pressure on insurers to cover the medication and similar weight loss treatments.

Persons: Doug Langa, Langa, Eli Lilly, Karsten Munk Knudsen, Wegovy Organizations: Novo Nordisk, balk, Novo Nordisk's, North, Nordisk, CNBC, U.S . Food, Drug Administration, National Institutes of Health Locations: U.S, Novo, North America

☆ For some cardiac patients with stents, long-term aspirin treatments might be on the way out
▼ + stars: | 2023-10-31 | by ( Giri Viswanathan | ) edition.cnn.com time to read: +6 min

For years, medical professionals widely recommended regular aspirin to prevent heart problems, since aspirin can reduce blood clotting to prevent complications like heart attacks or strokes. Still, many health care professionals still consider aspirin to be beneficial for many patients who have heart problems or have a stent. Dropping aspirin also reduced the risk of severe bleeding by nearly 50% compared with patients on the combination therapy, said Mehran — without increasing the risk of cardiac complications. Given the results of her clinical trial and a growing amount of evidence suggesting that long-term aspirin may not be beneficial for acute coronary syndrome, Mehran prescribes a treatment plan without long-term aspirin for her own patients. Aspirin remains ‘an essential therapy’However, experts agree that aspirin remains a beneficial medication for heart conditions.

Persons: ’ ”, Roxana Mehran, Mehran, ” Mehran, Aspirin, Dr, Harlan Krumholz, ticagrelor, Sanjay Gupta, ” Organizations: CNN, Icahn School of Medicine, World Health Organization, American College of Cardiology, American Heart Association, United States Preventive Services Task Force, Yale School of Medicine, CNN Health Locations: Mount Sinai, United States, South Korea

☆ Gen Z is lonely. Going back to the office may be the cure for some.
▼ + stars: | 2023-10-31 | by ( Aaron Mok | Lakshmi Varanasi | ) www.businessinsider.com time to read: +12 min

The solitude of remote work seemed to particularly hit Gen Z workers — who began their careers as workplaces went from in-person to virtual — hard. With companies asking — and in some cases mandating — their employees return to the office, Gen Z workers who are going in regularly have said they have a renewed sense of confidence in their jobs. Since Fitchett's employer started mandating employees go to the office, Fitchett said he finally feels a sense of ease at his job. Don't expect a full-scale return to the office quite yetThere's more that goes into a worker's preferences than loneliness, and Gen Z workers are mixed about returning to the office full time. For her — and many other Gen Z workers — the solution may come in some form of flexibility.

Persons: Ben Fitchett didn't, Fitchett, Ben Fitchett, Ben Fitchett Young, Aaron Terrazas, —, Cigna, Hubert Palan, Z, Covid —, Palan, Vivek Murthy, it's, Mansoor Soomro, Soomro, Gen, Juanita Garcia, Garcia, who've, Zers, Anita Pan —, Anita Pan, Pan, Ricky Yean, Zers —, Yean, Bianca Wu, Bianca Wu Bianca Wu, Wu, wouldn't Organizations: Company, Teesside University, Starbucks, Flow, Dell Locations: New Zealand, Los Angeles, New York, Washington , DC, Bay

☆ This biotech developing a cholesterol drug has a chance to triple, RBC predicts
▼ + stars: | 2023-10-30 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

NewAmsterdam Pharma 's latest drug treatment could lead investors to a windfall, according to RBC Capital Markets. Timashev believes obicetrapib, a cholesterol-lowering treatment, "can succeed where others have failed" due to the drug's specific and idiosyncratic properties. Additionally, the drug has a history of success, consistently demonstrating a 40% to 50% LDL reduction in patients. The analyst added that while current use cases for the drug involve lowering cardiovascular events, there's also potential upside for other applications. Specifically, there's a relationship between higher cholesterol levels and Alzheimer's disease, which could be an avenue for NewAmsterdam to explore for future treatment opportunities.

Persons: Leonid Timashev, Timashev, obicetrapib, there's, — CNBC's Michael Bloom Organizations: NewAmsterdam Pharma, RBC Capital Markets

☆ Loss of slow-wave sleep raises dementia risk, study finds
▼ + stars: | 2023-10-30 | by ( Kristen Rogers | ) edition.cnn.com time to read: +6 min

CNN —Loss of slow-wave sleep as you age may increase your risk of developing dementia, according to a new study. Slow-wave sleep is the third stage of sleep, which is important for brain health. Each percentage decrease in slow-wave sleep per year was linked with a 27% increased risk of developing dementia and a 32% higher risk of Alzheimer’s disease dementia. The rate of slow-wave sleep loss accelerated from age 60, peaked from ages 75 to 80 and slowed afterward. “This is an important study yet again showing the impact of quality of sleep on a person’s risk of cognitive decline and dementia,” Isaacson said.

Persons: ”, Matthew P, Pase, “, Richard Isaacson, Isaacson wasn’t, ” Pase, ” Isaacson, it’s, Rudolph Tanzi, Tanzi wasn’t, Pase’s Organizations: CNN, Monash University, Framingham Heart Study, US, Blood Institute, Study, Genetics, Aging Research, Massachusetts General Hospital, ” Locations: Australia, Florida, Framingham, Massachusetts

☆ How your seasonal chores count toward your fitness goals
▼ + stars: | 2023-10-28 | by ( Dana Santas | ) edition.cnn.com time to read: +6 min

What a lot of people don’t realize is that those seasonal chores are functional exercises that can burn more calories than some traditional fitness activities. Unfortunately, too many people forget to use that mindset when doing seasonal chores. Use proper formJust as you would execute an exercise at the gym, you want to perform your seasonal chores with the same attention to proper form. Switch sidesBecause most humans have a dominant side, we tend to favor that side while doing chores. It’s important to take water breaks while doing chores and to stay hydrated after you have finished your work.

Persons: Dana Santas, What’s, Kentaroo Organizations: Pain, CNN, American Council Locations: United States

Such forecasts have prompted a sell-off in a wide range of companies from makers of bariatric surgery devices to companies whose products address the health issues created by excess weight, from diabetes to sleep apnea. "The market is in a shoot-first, ask-questions-later mood when it comes to weight-loss drugs," said Nicholas Anderson, manager of the Thornburg International Growth Fund, which holds shares of Novo Nordisk. By contrast, the iShares U.S. Medical Devices exchange-traded fund has lost more than 22% in the last three months. Injectable weight-loss drugs, known as GLP-1 receptor agonists, are considered highly effective but are also expensive, costing more than $1,300 per month. "Overall, we'll see an increased interest in bariatric surgery, but that will get delayed in the short term."

Persons: Doctor Thomas Horbach, Wegovy, Nicholas Anderson, Eli Lilly, Kenneth Stein, Margaret Kaczor Andrew, William Blair, Michael Farrell, Jeff Jonas, Johnson, Myriam Curet, Ann Hynes, Hynes, David Gaffen, Manas, Michael Erman, Caroline Humer, Sonali Paul Organizations: Novo Nordisk, Healthcare, Growth Fund, Medical Devices, Boston, Gabelli Funds, Johnson, Reuters, Mizuho Securities, Manas Mishra, Thomson Locations: Germany, Munich, Danish, U.S, Boston, GLP, New York, Bengaluru

☆ Counting time instead of calories also controls blood sugar and belly fat
▼ + stars: | 2023-10-27 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +7 min

“Controlling blood sugar is more important for those with type 2 diabetes, but losing weight (specifically visceral fat) usually leads to better blood sugar control,” she added. However, there was no loss of lean muscle mass in the new study, Varady said. “I definitely lost weight when I did it,” said Weiss, who is affiliated with the Cardiovascular Research Institute at the University of California, San Francisco. Cavan Images/Cavan Images RF/Getty ImagesEveryone is differentThe best route to weight loss can differ from person to person, experts say, which is one reason why there are so many dietary options. Time-restricted eating is right for some, but not for others, Katz said.

Persons: ”, Krista Varady, Varady, ” Varady, “, David Katz, Katz, ” Katz, Ethan Weiss, Weiss, ” Weiss, they’re Organizations: CNN —, University of Illinois, A1C, True Health Initiative, Cardiovascular Research, University of California Locations: University of Illinois Chicago, San Francisco, Cavan

☆ Longevity doctor shares No. 1 supplement he's been taking every day to 'slow down aging'—and how he feels now
▼ + stars: | 2023-10-27 | by ( Neil Paulvin | ) www.cnbc.com time to read: +3 min

It can stimulate stem cell production. It can help repair DNA. It can lower blood pressure. Taurine has demonstrated the potential to lower blood pressure through several mechanisms. Taurine has also been shown to inhibit the release of stress hormones like cortisol, which can raise blood pressure.

Persons: I've, Taurine Locations: Taurine

☆ Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
▼ + stars: | 2023-10-23 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. Last month, the firm made a case for there being a $150 billion to $200 billion opportunity for these drugs. At the moment, private insurance coverage isn't a guarantee for those seeking weight loss treatment, and the federal Medicare program doesn't cover weight loss drugs at all. Lilly expects the Food and Drug Administration to approve this drug to treat obesity by the end of this year.

Persons: Seamus, Fernandez, Andrew Baum, Goldman Sachs, Chris Shibutani, Shibutani, Eli Lilly, Lilly Organizations: Monday, Citi, Wegovy, Food and Drug Administration Locations: GLP

☆ Move over, Peloton. Rucking is the newest fitness craze in Silicon Valley and beyond.
▼ + stars: | 2023-10-23 | by ( Samantha Stokes | ) www.businessinsider.com time to read: +10 min

Memon, who cofounded the artificial-intelligence healthcare startup Eureka Health, credits rucking with conditioning his body to keep up with his high-energy pup. Memon hiking around the Bay Area with a weighted backpack. She told Insider she'd seen an uptick in people interested in adding rucking and weight training to their outdoor activities like trail running and hiking. He doesn't ruck outside but wears a weighted vest purchased from Amazon while completing his routine in the gym, which includes time on the StairMaster as well as lifting traditional weights. The venture capitalist Zamir Shukho's dog, Lord Lincoln, wears a weighted vest on walks.

Persons: Zain Memon, Joy, Zain Memon Memon, Memon, It's, —, Henry Merriam, REI, Wilson Kriegel, — Kriegel, Wendy Winn, she'd, Winn, Charlie Hale, I'm, Amanda Bradford, rucking, She's, Bradford, I've, Zamir Shukho's, Lord Lincoln, Zamir Shukho, begrudgingly, Vibranium.VC Organizations: Eureka Health, US Army, National Parks Service, Amazon, Group Locations: Buena Vista, Sutro, San Francisco, Silicon, TikTok, North, New York City, New York, Los Angeles, Austin , Texas, Bird, American Staffordshire

☆ As Abortion Access Shrinks, Hospitals Fill in the Gaps
▼ + stars: | 2023-10-23 | by ( Allison Mccann | ) www.nytimes.com time to read: +16 min

As Abortion Access Shrinks, Hospitals Fill in the Gaps For this article, Allison McCann and Jamie Kelter Davis spent time with a patient from Indiana as she underwent an abortion at a Chicago hospital. Alaska Fla. Hawaii 16% 18% 20%+ Total or six-week abortion ban Wash. Maine Mont. Dr. Jonah Fleisher is a co-director of the Complex Abortion Regional Line for Access, or CARLA, which helps abortion patients find appointments at four Chicago-area hospitals. Chronic Conditions and Abortion Bans These health conditions, especially when left untreated, can add risks for abortion patients. Alaska Fla. Hawaii Diabetes among women High blood pressure among women Cardiovascular disease among women 9% 11% 13%+ 28% 30% 32%+ 5% 6% 7%+ Total or 6-week abortion ban Total or 6-week abortion ban Total or 6-week abortion ban Wash. Wash. Wash. Maine Mont.

Persons: Allison McCann, Jamie Kelter Davis, ”, “, Roe, Wade, Conn ., Dobbs, Jenni Villavicencio, Jonah Fleisher, CARLA, Laura Laursen, Laursen, Dr, Conn . Conn ., Kan ., Nev, PolicyMap, “ It’s, Allison Cowett, Erica Hinz, couldn’t, Caroline Nyheim, Qudsiyyah Shariyf, Megan Jeyifo, J.B . Pritzker, CARLA —, — you’re, Mr, Pritzker Organizations: ” RUSH University Medical Center, Health, Ore, Conn . Pa . Iowa Neb, N.J . Ohio Nev, Ill . Utah Md, ., . Ill . Utah Md, OB, Society for Family Planning, Midwest, RUSH University Medical Center, Diabetes, Conn . Pa . Iowa Neb . Ohio Nev, N.J ., N.M, Hawaii Diabetes, N.D ., Vt, Wis ., Pa . Conn . Iowa Neb, Pa . Iowa Iowa Nev, Nev . N.J ., Ariz . D.C, Black, S.C . Iowa Miss, Nev . D.C, White, Family Planning, Chicago Abortion Fund, South, Nurses, Chicago Abortion, Illinois, Gov Locations: Indiana, Chicago, Indianapolis, . Maine, N.D, Vt, Minn, N.H . Wis, Idaho, S.D, Mich, Conn, Conn . Pa . Iowa, N.J . Ohio, Ind, Ill . Utah, W.Va, Colo . Va, Kan, Calif, Mo, Ky, R.I, N.C, Tenn, Del, ., S.C ., Ga, Ala . Miss . Texas La, Alaska Fla, Hawaii, N.J, Nev . Ohio, . Ill . Utah, R.I . Tenn, Okla, Illinois, N.H . Wis . Idaho, Wyo, Conn . Pa . Iowa Neb . Ohio, N.J . Ind, Ariz ., Pa . Conn . Iowa, . Ind, . Ark, N.H, Wis . Idaho S.D, N.Y, Wash . Maine, N.D . Maine Maine Mont, Mont, Minn . Vt, Ore, Mass, Wis, Wis . Idaho Idaho, Conn . Conn, Conn . Conn . Pa, Pa . Iowa, Pa . Iowa Iowa Nev . Ohio, Neb . Ohio, Nev . N.J, Nev . N.J . Ohio, W.Va . Ind, Ill, Colo . Utah Utah Md, Md, W.Va . Va . Colo, Colo, Ky . Va . Va, Kan . Kan, R.I . Ky, Okla . Tenn, Ariz . Ark, Ala . Miss ., Ala . Ala . Miss, . Texas La . Texas Texas, La . Alaska Alaska Alaska Fla, Fla, Hawaii Hawaii Hawaii, Ohio, Pa . Minn, Neb, Mo . Md, Ala, Wash, Ky . N.J, Conn . Va . Ind, S.C . Iowa, Ariz, Tex, Nev ., Fla ., Massachusetts

☆ Running for Our Lives
▼ + stars: | 2023-10-21 | by ( Melissa Kirsch | More About Melissa Kirsch | ) www.nytimes.com time to read: +2 min

The obvious answer is that we run to be healthy, to improve our cardiovascular systems and our moods, to become fitter and stronger. But sometimes it feels like the real reason that I run is to get better at running. But running in particular seems intricately linked to questions of endurance, of grit and commitment and even moral rectitude. “Running is more than a sport or a form of exercise, a passion or a pastime. I started running because I wanted to reclaim the practice from my elementary school days, when the Presidential Fitness Test — and its crowning glory, the mile run — was accepted as a meaningful measure of a child’s worth.

Persons: We’ve, it’s Organizations: American College of Cardiology

☆ Why You Might Be Drinking Too Much Without Knowing It
▼ + stars: | 2023-10-20 | by ( Josh Zumbrun | ) www.wsj.com time to read: 1 min

Modelo Especial is now America’s top-selling beer, dethroning the longstanding king, Bud Light, which recently has been subject to a culture-war storm. Here’s how an antitrust lawsuit and savvy marketing helped the Mexican brand grow in the U.S. Photo: Mario Tama/Getty ImagesA number of readers were surprised by my recent column that mentioned “regular drinkers” might have a lifespan as much as seven years shorter than nondrinkers. Haven’t many studies over the years suggested some benefit from an occasional drink, especially against cardiovascular diseases? There are a number of reasons why drinking shortens lifespans, and one is that we have lost track of what a “drink” actually is.

Persons: Bud Light, Mario Tama Organizations: Modelo Especial Locations: Mexican, U.S

☆ AI holds promise for fast-tracking treatment and personalizing medicine — but it may not come to your clinic anytime soon
▼ + stars: | 2023-10-20 | by ( Heather Lindsey | ) www.businessinsider.com time to read: +6 min

Tsai predicts that AI will one day help doctors analyze complicated genetic data — a hallmark of precision medicine. Together, AI imaging and genetic analysis may help doctors rapidly pinpoint a diagnosis and create a highly personalized treatment plan, thus improving a patient's care. AI and the potential for genetic analysisIn addition to medical imaging, AI could one day comb through large amounts of genetic information, a challenging task for researchers. A possible convergence in the clinicWang does not see combining AI imaging and AI genetic analysis at the doctor's office happening within the next couple of years. Chang and his colleagues are investigating how AI analysis of brain scans can predict genetic mutations in brain tumors.

Persons: James C, Tsai, Peter D, Chang, Zhenghe J, Wang Organizations: Healthcare, Morning, Center, Ophthalmic Artificial Intelligence, Human, Icahn School of Medicine, US Food and Drug Administration, Applied, Research, University of California, Case Western Reserve University Locations: Mount, Irvine

☆ Red meat linked to risk of type 2 diabetes, study finds
▼ + stars: | 2023-10-19 | by ( Kristen Rogers | ) edition.cnn.com time to read: +7 min

I hope our study could settle the debate regarding whether we should limit red meat intake for health concerns or not.”Eating certain amounts of red meat has been linked with higher risk of developing type 2 diabetes. The authors studied 216,695 people who had participated in the Nurses’ Health Study, the Nurses’ Health Study II and the Health Professionals Follow-up Study, all of which recruited participants from around 1976 to 1989. Eating the most processed or unprocessed red meat was linked with a 51% and 40% higher risk of type 2 diabetes, respectively. But multiple biological factors could have affected the relationship between red meat and type 2 diabetes, the authors said. “Consistently reported, dairy, legumes and nuts are the best foods with which to replace the red meat,” she added.

Persons: ”, Xiao Gu, ” Gu, White, Alice Lichtenstein, Gershoff, Lichtenstein wasn’t, Lichtenstein, Gunter Kuhnle, wasn’t, “, Walter C, Willett, Harvard T.H, Gu Organizations: CNN, Harvard, American, Clinical Nutrition, of Public Health, Nurses, Health, NHS, Nutrition Science, Tufts University, Nutrition Laboratory, University of Reading Locations: Chan, North America, Boston

☆ HealthCaters enables people to screen themselves at home for preventable diseases. Check out the 14-slide pitch deck it used to raise $1.2 million.
▼ + stars: | 2023-10-19 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +2 min

A startup that offers personalized health screenings for individuals and employees has just raised $1.2 million in fresh funds. Berlin-based HealthCaters, which was founded three years ago, has developed a home-testing kit so that users can screen themselves for preventable diseases. The startup's app, which is also powered by AI, then suggests personalized health guidelines based on the results of these screenings. Based on these results, medical coaches at the startup create an individual health plan for patients. With the fresh funding, HealthCaters will double down on its business-to-business offerings, and eye a launch in the UK market.

Persons: Tatyana Eliseeva, aren't, Daniel Ek, Dr, Lilia Kruse, HealthCaters Organizations: IBM, DvH Ventures Locations: Berlin, HealthCaters, Germany, Europe

☆ Common contaminants linked to accelerated weight gain in children
▼ + stars: | 2023-10-19 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +8 min

The research network aims to examine the lifetime impact of exposure in the womb to chemical contaminants in air, water and food. Both DDT and HCB contamination in people occurs “mainly through bioaccumulation in the food chain via fish, fish products, meat (and) dairy products,” Montazeri said. The July 2022 report also found PFAS exposure was sufficiently associated with decreased infant and fetal growth as well as decreased antibody response to vaccines in both adults and children. Pregnant people can take steps to reduce their exposure to various chemicals in commercial products, food and water. “Phthalates and phenols come from plastics and personal care products,” Montazeri said.

Persons: ”, Parisa Montazeri, “, Montazeri, Leonardo Trasande, HCB, ” Montazeri, Trasande Organizations: CNN, Barcelona Institute, Global Health, BMI, NYU Langone Health, Environmental, US Centers for Disease Control, CDC, US Environmental Protection Agency, National Academies of Sciences, Engineering, Medicine, Getty, NYU’s Grossman School of Medicine, National Sanitation Foundation Locations: Spain, United States, PFAS

☆ Opinion | Beyond ‘Deaths of Despair’
▼ + stars: | 2023-10-18 | by ( David Wallace-Wells | ) www.nytimes.com time to read: +4 min

Those million extra deaths exceed even the nearly 700,000 who die each year from cardiovascular disease, the country’s biggest killer. In 2021, the researchers found, extra mortality accounted for nearly one in every three American deaths. “The United States is failing at a fundamental mission — keeping people alive,” The Washington Post recently concluded, in a remarkable series on the country’s mortality crisis. But by almost every other measure the United States is lagging its peers, often catastrophically. It’s not quite right to call all this simply “despair,” even if social anomie plays a role.

Persons: Matthews, “, Jimmy Carter, ”, Covid, It’s, Deaton, America ” Organizations: Washington Post, European Union, Organization for Economic Cooperation, Development Locations: Bor, United States, Virginia, Louisiana, Kansas, States, Netherlands, Sweden, America

☆ Mediterranean diet and exercise reduce dangerous belly fat, study says
▼ + stars: | 2023-10-18 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +7 min

In addition to a loss of overall body fat, participants in the study lost dangerous visceral belly fat, which could lead to diabetes, heart disease and stroke. If visceral fat is about 10% of your body’s total fat mass, that’s normal and healthy, according to the Cleveland Clinic. Too much visceral fat, however, can create inflammation, contributing to chronic disease. A lower-calorie Mediterranean diet could include proteins such as salmon, chicken breast and tuna, as well as fruits, vegetables, nuts, seeds, legumes and olive oil. However, “only participants from the intervention group decreased grams of visceral fat mass,” while visceral fat mass remained unchanged in the control group, according to the study.

Persons: ”, David Katz, Katz, Walter Willett, Harvard T.H, “, Willett, Gunter Kuhnle, ” Kuhnle, Christopher Gardner, ” Gardner Organizations: CNN, True Health Initiative, Cleveland Clinic, Harvard, of Public Health, Harvard Medical School, JAMA, University of Reading, Stanford Prevention Research, Nutrition Studies Research Locations: Chan, Boston, Spain, United Kingdom, California

The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. J&J raised its annual profit forecast, helped by strong sales from its pharmaceutical business, and shares of the U.S. healthcare conglomerate were off about 1%. Excluding its consumer health unit, J&J now expects 2023 adjusted profit of $10.07 to $10.13 per share, up from its previous view of $10.00 to $10.10. Sales at J&J's medical device unit came in at $7.46 billion, shy of Wall Street estimates of $7.58 billion. J&J finalized the biggest shake-up in its 137-year history in August with the spinoff, but retained a 9.5% stake in its iconic consumer health business.

Persons: Johnson, Yves Herman, J, Vamil Divan, Joseph Wolk, Ozempic, Wolk, Bhanvi Satija, Sriparna Roy, Patrick Wingrove, Shounak Dasgupta, Bill Berkrot Organizations: Johnson, REUTERS, Guggenheim Partners, Vamil, Reuters Graphics, J, Thomson, &' $, & $, & $ Locations: Brussels, Diegem, Belgium, Bengaluru, New York

☆ Novo Nordisk in $1.3 bln deal to buy hypertension drug
▼ + stars: | 2023-10-16 | by ( ) www.reuters.com time to read: +1 min

Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsCOPENHAGEN, Oct 16 (Reuters) - Novo Nordisk (NOVOb.CO) has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular and kidney disease, from KBP Biosciences for up to $1.3 billion, the Danish drugmaker said on Monday. "This deal is closely aligned with our strategic focus on expanding from our core in diabetes into other serious chronic diseases, including through novel drug modalities," Novo said in a statement. The acquisition is expected to close before the end of this year, Novo said, adding that the deal will not impact its operating profit outlook for 2023. Ocedurenone is an orally administered drug that is currently examined in the phase 3 trial CLARION-CKD in patients with uncontrolled hypertension and advanced chronic kidney disease, Novo said.

Persons: Tom Little, Danish drugmaker, Novo, Louise Breusch Rasmussen, Terje Solsvik Organizations: Novo Nordisk, Danish, REUTERS, Rights, KBP Biosciences, CLARION, Thomson Locations: Copenhagen, Denmark, Rights COPENHAGEN, Danish

☆ This highly profitable industry is booming as the population ages
▼ + stars: | 2023-10-15 | by ( Michelle Fox | ) www.cnbc.com time to read: +10 min

Enteral nutrition is administered through a feeding tube or it can be taken orally. Fresenius owns 32% of Fresenius Medical Center, which saw shares drop on recent news that Ozempic's kidney disease treatment trial showed signs of success. Clinical nutrition is about 20% of group profits and an important subset of its larger specialized nutrition unit, Ackerman said. "Many investors only focus only on their infant formula unit and don't know how big or how profitable clinical nutrition is," he said. "Clinical nutrition is the jewel in Danone's crown and probably the most attractive part of Danone's portfolio, yet is hidden from investors."

Persons: Stefano Natella, — hasn't, Hassan Al, Wakeel, Warren Ackerman, Ackerman, Lindsay Clarke, Enteral, Danone's Nutrison, —, Baxter, Abbott, Sara Hennicken, Fresenius, Nestlé, Mark Schneider, Nestle, — CNBC's Michael Bloom Organizations: Guggenheim, World Health Organization, WHO, Barclays, Danone, Fresenius, Al, Alliance for Aging Research, Aging, CNBC, Nestle, Companies, — Nestle, Nutrition, Fresenius Medical Locations: German, Paris, China, Swiss, United States, parenteral, Latin America

☆ 'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
▼ + stars: | 2023-10-14 | by ( Anna Gleason | ) www.cnbc.com time to read: +2 min

Two experts see major challenges facing the adoption of new obesity drugs. However, she considers data supporting the use of obesity drugs for other conditions including Alzheimer's and alcohol addiction as underdeveloped. Novo Nordisk halted FLOW on Tuesday. As of Friday's close, Novo Nordisk is up 9.82% since its announcement. "Right now, we are seeing active employers, entire states that are declining to cover on the weight loss indication," Patel said.

Persons: Kavita Patel, CNBC's, I've, Eli Lilly, Patel, Obama Organizations: NBC, Novo Nordisk, Nordisk, White, Health Locations: Novo

Search resuls for: "Cardiovascular"

25 mentions found